+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug Discovery Market-Technologies, Market share and Industry Forecast to 2024

  • ID: 4719666
  • Report
  • Region: Global
  • 240 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Drug Discovery Market is Projected to Grow Impressive CAGR of 9%

FEATURED COMPANIES

  • Astrazeneca (U.K)
  • Covance. (U.S.)
  • Eli Lily (U.S)
  • Glaxosmithkline Plc (UK)
  • Pfizer, Inc. (U.S.)
  • Viva Biotech (China)
  • MORE

The market for the global drug discovery is highly affected due to the scientific and technological changes and advancements that are continuously taking place around the world. This market contributes highly in the growth of whole pharmaceutical industry as they help in introduction of new drugs.

The global drug discovery market is projected to grow impressive during the forecasted period growing at a CAGR of 9% during 2017-2024. Adoption of global drug discovery market is driven by following factors, such as rising incidences of chronic diseases, rising demand for novel drug discovery technologies and advancement in field of biotechnology.

The factors that restrain the growth of the global drug discovery market are the slow growth and development of new drugs may hamper the growth of this market. Also, the expiry of patents of the major drugs and the huge cost and time factor that is involved in the drug discovery hamper the growth of the global drug discovery market.

North America leads the global market for drug discovery due to the presence of manufacturing and research facilities in the region; also, it is the largest consumer of the branded drugs. This region is most lucrative as large number of leading pharmaceutical company’s presence. North America countries such as U.S. and Canada have formulated policies for encouraging investors for research in drug development and discovery. 

Asia Pacific market is driven by rise in the number contract research organizations. Asia-pacific is fastest growing region due to the presence of skilled labor at affordable cost, rise in disposable income and favorable government policies are also contributing in the market growth.

Global drug discovery market involves the process by which medications are discovered. These drugs are discovered by identifying the active ingredient by serendipitous discovery. The report scope of global drug discovery market covers segmentation analysis of drug type, technology, service and end-user. Drug type segment of global drug discovery market includes:  small molecule drug and biologics drug.

Technology segment of global drug discovery market includes: high throughput screening, biochips, bioinformatics, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics and other technologies.

Service segment of global drug discovery market includes:  Drug Metabolism and Pharmacokinetics (DMPK) services, pharmaceutical services, chemical services and biological services. End-user segment of global drug discovery market includes: research institutes, pharmaceutical companies, biotechnology companies and other end users.

Major players present in the market includes Pfizer (U.S.), GlaxoSmithKline PLC (UK), Johnson and Johnson (U.S), Bayer (Germany) and others. Further, presence of these major players in the market is expected to increase the opportunity for innovation in the field of global drug discovery market. Mergers & acquisitions, product launches, etc. are the major strategies adopted for expansion of business in global drug discovery market.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astrazeneca (U.K)
  • Covance. (U.S.)
  • Eli Lily (U.S)
  • Glaxosmithkline Plc (UK)
  • Pfizer, Inc. (U.S.)
  • Viva Biotech (China)
  • MORE

1.Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Drug Discovery Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porter’s 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Prevalence Of Chronic Diseases
3.1.2. Technological Advancements And Innovations
3.1.3. Increasing Healthcare Expenditure
3.1.4. Increasing Drug Approvals By Government Organization
3.2. Market Restraints
3.2.1. Stringent Government Regulations
3.2.2. Huge Capital Investment With Low Profit Margins
3.3. Market Opportunities
3.3.1. Enhancement In Population Of Affluent Patients
3.3.2. Rise In Drug Discovery Outsourcing
3.4. Market Challenges
3.4.1. High Amount Of Investment
3.4.2. Requires A Long Time Span

4. Global Drug Discovery Market By Drug Type
4.1. Market Definition And Scope
4.2. Decision Support Database & Estimation Methodology
4.3. Comparative Analysis Across Market Segments
4.4. Opportunity Matrix
4.5. Market Segmentation
4.5.1. Global Small Molecule Drug Market
4.5.1.1. Adoption Scenario & Market Determinants
4.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.1.3. Key Conclusions
4.5.2. Global Biologics Drug Market
4.5.2.1. Adoption Scenario & Market Determinants
4.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.2.3. Key Conclusions

5. Global Drug Discovery Market By Technology
5.1. Market Definition And Scope
5.2. Decision Support Database & Estimation Methodology
5.3. Comparative Analysis Across Market Segments
5.4. Opportunity Matrix
5.5. Market Segmentation
5.5.1. Global High Throughput Screening Market
5.5.1.1. Adoption Scenario & Market Determinants
5.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.1.3. Key Conclusions
5.5.2. Global Biochips Market
5.5.2.1. Adoption Scenario & Market Determinants
5.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.2.3. Key Conclusions
5.5.3. Global Bioinformatics Market
5.5.3.1. Adoption Scenario & Market Determinants
5.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.3.3. Key Conclusions
5.5.4. Global Pharmacogenomics And Pharmacogenetics Market
5.5.4.1. Adoption Scenario & Market Determinants
5.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.4.3. Key Conclusions
5.5.5. Global Combinatorial Chemistry Market
5.5.5.1. Adoption Scenario & Market Determinants
5.5.5.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.5.3. Key Conclusions
5.5.6. Global Nanotechnology Market
5.5.6.1. Adoption Scenario & Market Determinants
5.5.6.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.6.3. Key Conclusions
5.5.7. Global Spectroscopy Market
5.5.7.1. Adoption Scenario & Market Determinants
5.5.7.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.7.3. Key Conclusions
5.5.8. Global Metabolomics Market
5.5.8.1. Adoption Scenario & Market Determinants
5.5.8.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.8.3. Key Conclusions
5.5.9. Global Other Technologies Market
5.5.9.1. Adoption Scenario & Market Determinants
5.5.9.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.9.3. Key Conclusions

6. Global Drug Discovery Market By Service
6.1. Market Definition And Scope
6.2. Decision Support Database & Estimation Methodology
6.3. Comparative Analysis Across Market Segments
6.4. Opportunity Matrix
6.5. Market Segmentation
6.5.1. Global Drug Metabolism And Pharmacokinetics (Dmpk) Services Market
6.5.1.1. Adoption Scenario & Market Determinants
6.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.5.1.3. Key Conclusions
6.5.2. Global Pharmaceutical Services Market
6.5.2.1. Adoption Scenario & Market Determinants
6.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.5.2.3. Key Conclusions
6.5.3. Global Chemical Services Market
6.5.3.1. Adoption Scenario & Market Determinants
6.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.5.3.3. Key Conclusions
6.5.4. Global Biological Services Market
6.5.4.1. Adoption Scenario & Market Determinants
6.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.5.4.3. Key Conclusions

7. Global Drug Discovery Market By End User
7.1. Market Definition And Scope
7.2. Decision Support Database & Estimation Methodology
7.3. Comparative Analysis Across Market Segments
7.4. Opportunity Matrix
7.5. Market Segmentation
7.5.1. Global Research Institutes Market
7.5.1.1. Adoption Scenario & Market Determinants
7.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
7.5.1.3. Key Conclusions
7.5.2. Global Pharmaceutical Companies Market
7.5.2.1. Adoption Scenario & Market Determinants
7.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
7.5.2.3. Key Conclusions
7.5.3. Global Biotechnology Companies Market
7.5.3.1. Adoption Scenario & Market Determinants
7.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
7.5.3.3. Key Conclusions
7.5.4. Global Other End Users Market
7.5.4.1. Adoption Scenario & Market Determinants
7.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
7.5.4.3. Key Conclusions

8. Competitive Landscape
8.1. Key Strategies
8.1.1. List Of Merger & Acquisition
8.1.2. List Of Joint Venture
8.1.3. List Of Product Launches
8.1.4. List Of Partnership

9. Geographic Analysis
9.1. Decision Support Database & Estimation Methodology
9.2. Comparative Analysis Across Market Segments
9.3. Opportunity Matrix
9.4. Global Drug Discovery Market By Region 2015-2024 ($ Million)
9.4.1. North America
9.4.1.1. Industry Analysis 2015-2024 ($ Million)
9.4.1.2. Top Country Analysis
9.4.1.2.1. U.S.
9.4.1.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.1.2.1.3. Key Conclusions
9.4.1.2.2. Canada
9.4.1.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.1.2.2.3. Key Conclusions
9.4.2. Europe
9.4.2.1. Industry Analysis 2015-2024 ($ Million)
9.4.2.2. Top Country Analysis
9.4.2.2.1. UK
9.4.2.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.2.2.1.3. Key Conclusions
9.4.2.2.2. France
9.4.2.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.2.2.2.3. Key Conclusions
9.4.2.2.3. Germany
9.4.2.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.2.2.3.3. Key Conclusions
9.4.2.2.4. Russia
9.4.2.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.2.2.4.3. Key Conclusions
9.4.2.2.5. Rest Of Europe
9.4.2.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.2.2.5.3. Key Conclusions
9.4.3. Asia Pacific
9.4.3.1. Industry Analysis 2015-2024 ($ Million)
9.4.3.2. Top Country Analysis
9.4.3.2.1. China
9.4.3.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.3.2.1.3. Key Conclusions
9.4.3.2.2. India
9.4.3.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.3.2.2.3. Key Conclusions
9.4.3.2.3. Japan
9.4.3.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.3.2.3.3. Key Conclusions
9.4.3.2.4. Australia
9.4.3.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.3.2.4.3. Key Conclusions
9.4.3.2.5. Rest Of Asia Pacific
9.4.3.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.3.2.5.3. Key Conclusions
9.4.4. Row
9.4.4.1. Industry Analysis 2015-2024 ($ Million)
9.4.4.2. Top Country Analysis
9.4.4.2.1. Latin America
9.4.4.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.4.2.1.3. Key Conclusions
9.4.4.2.2. Middle East & Africa
9.4.4.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
9.4.4.2.2.3. Key Conclusions

10. Company Profiles
10.1. Astrazeneca (U.K)
10.1.1. Overview
10.1.2. Product Portfolio
10.1.3. Strategic Initiatives
10.1.4. Scot Analysis
10.1.5. Strategic Analysis
10.2. Albany Moleculer Research (U.S.)
10.2.1. Overview
10.2.2. Product Portfolio
10.2.3. Strategic Initiatives
10.2.4. Scot Analysis
10.2.5. Strategic Analysis
10.3. Bayer (Germany)
10.3.1. Overview
10.3.2. Product Portfolio
10.3.3. Strategic Initiatives
10.3.4. Scot Analysis
10.3.5. Strategic Analysis
10.4. Boehringer Ingelheim (Germany)
10.4.1. Overview
10.4.2. Product Portfolio
10.4.3. Strategic Initiatives
10.4.4. Scot Analysis
10.4.5. Strategic Analysis
10.5. Covance. (U.S.)
10.5.1. Overview
10.5.2. Product Portfolio
10.5.3. Strategic Initiatives
10.5.4. Scot Analysis
10.5.5. Strategic Analysis
10.6. Cyprotex. (U.K.)
10.6.1. Overview
10.6.2. Product Portfolio
10.6.3. Strategic Initiatives
10.6.4. Scot Analysis
10.6.5. Strategic Analysis
10.7. Eli Lily (U.S)
10.7.1. Overview
10.7.2. Product Portfolio
10.7.3. Strategic Initiatives
10.7.4. Scot Analysis
10.7.5. Strategic Analysis
10.8. Glaxosmithkline Plc (UK)
10.8.1. Overview
10.8.2. Product Portfolio
10.8.3. Strategic Initiatives
10.8.4. Scot Analysis
10.8.5. Strategic Analysis
10.9. Genscript (U.S)
10.9.1. Overview
10.9.2. Product Portfolio
10.9.3. Strategic Initiatives
10.9.4. Scot Analysis
10.9.5. Strategic Analysis
10.10.  Johnson And Johnson (U.S)
10.10.1. Overview
10.10.2. Product Portfolio
10.10.3. Strategic Initiatives
10.10.4. Scot Analysis
10.10.5. Strategic Analysis
10.11.  Pfizer, Inc. (U.S.)
10.11.1. Overview
10.11.2. Product Portfolio
10.11.3. Strategic Initiatives
10.11.4. Scot Analysis
10.11.5. Strategic Analysis
10.12.  Quintiles (U.S)
10.12.1. Overview
10.12.2. Product Portfolio
10.12.3. Strategic Initiatives
10.12.4. Scot Analysis
10.12.5. Strategic Analysis
10.13.  Viva Biotech (China)
10.13.1. Overview
10.13.2. Product Portfolio
10.13.3. Strategic Initiatives
10.13.4. Scot Analysis
10.13.5. Strategic Analysis
10.14.  WIL Research Laboratories (U.S.)
10.14.1. Overview
10.14.2. Product Portfolio
10.14.3. Strategic Initiatives
10.14.4. Scot Analysis
10.14.5. Strategic Analysis
10.15.  WuXi Apptech (China)
10.15.1. Overview
10.15.2. Product Portfolio
10.15.3. Strategic Initiatives
10.15.4. Scot Analysis
10.15.5. Strategic Analysis
 
List Of Tables
1. Global Drug Discovery Market By Drug Type 2015-2024 ($ Million)
2. Global Small Molecule Drug Market By Geography 2015-2024 ($ Million)
3. Global Biologics Drug Market By Geography 2015-2024 ($ Million)
4. Global Drug Discovery Market By Technology 2015-2024 ($ Million)
5. Global High Throughput Screening Market By Geography 2015-2024 ($ Million)
6. Global Biochips Market By Geography 2015-2024 ($ Million)
7. Global Bioinformatics Market By Geography 2015-2024 ($ Million)
8. Global Pharmacogenomics And Pharmacogenetics Market By Geography 2015-2024 ($ Million)
9. Global Combinatorial Chemistry Market By Geography 2015-2024 ($ Million)
10. Global Nanotechnology Market By Geography 2015-2024 ($ Million)
11. Global Spectroscopy Market By Geography 2015-2024 ($ Million)
12. Global Metabolomics Market By Geography 2015-2024 ($ Million)
13. Global Other Technologies Market By Geography 2015-2024 ($ Million)
14. Global Drug Discovery Market By Service 2015-2024 ($ Million)
15. Global Drug Metabolism And Pharmacokinetics (DMPK) Services Market By Geography 2015-2024 ($ Million)
16. Global Pharmaceutical Services Market By Geography 2015-2024 ($ Million)
17. Global Chemical Services Market By Geography 2015-2024 ($ Million)
18. Global Biological Services Market By Geography 2015-2024 ($ Million)
19. Global Drug Discovery Market By End User 2015-2024 ($ Million)
20. Global Research Institutes Market By Geography 2015-2024 ($ Million)
21. Global Pharmaceutical Companies Market By Geography 2015-2024 ($ Million)
22. Global Biotechnology Companies Market By Geography 2015-2024 ($ Million)
23. Global Other End Users Market By Geography 2015-2024 ($ Million)
24. North America Drug Discovery Market 2015-2024 ($ Million)
25. Europe Drug Discovery Market 2015-2024 ($ Million)
26. Asia Pacific Drug Discovery Market 2015-2024 ($ Million)
27. Rest Of The World Drug Discovery Market 2015-2024 ($ Million)
28. North America Drug Discovery Market By Drug Type 2015-2024 ($ Million)
29. Europe Drug Discovery Market By Drug Type 2015-2024 ($ Million)
30. Asia Pacific Drug Discovery Market By Drug Type 2015-2024 ($ Million)
31. Rest Of The World Drug Discovery Market By Drug Type 2015-2024 ($ Million)
32. North America Drug Discovery Market By Technology 2015-2024 ($ Million)
33. Europe Drug Discovery Market By Technology 2015-2024 ($ Million)
34. Asia Pacific Drug Discovery Market By Technology 2015-2024 ($ Million)
35. Rest Of The World Drug Discovery Market By Technology 2015-2024 ($ Million)
36. North America Drug Discovery Market By Service 2015-2024 ($ Million)
37. Europe Drug Discovery Market By Service2015-2024 ($ Million)
38. Asia Pacific Drug Discovery Market By Service 2015-2024 ($ Million)
39. Rest Of The World Drug Discovery Market By Service 2015-2024 ($ Million)
40. United States Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
41. United States Global Drug Discoveryby Technology 2015-2024 ($ Million)
42. United States Global Drug Discoveryby Service 2015-2024 ($ Million)
43. United States Global Drug Discovery By End User 2015-2024 ($ Million)
44. Canada Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
45. Canada Global Drug Discoveryby Technology 2015-2024 ($ Million)
46. Canada Global Drug Discoveryby Service 2015-2024 ($ Million)
47. Canada Global Drug Discoveryby End User 2015-2024 ($ Million)
48. UK Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
49. UK Global Drug Discoveryby Technology 2015-2024 ($ Million)
50. UK Global Drug Discoveryby Service 2015-2024 ($ Million)
51. UK Global Drug Discoveryby End User 2015-2024 ($ Million)
52. Germany Global Drug Discovery By Drug Type 2015-2024 ($ Million)
53. Germany Global Drug Discovery By Technology 2015-2024 ($ Million)
54. Germany Global Drug Discoveryby Service 2015-2024 ($ Million)
55. Germany Global Drug Discoveryby End User 2015-2024 ($ Million)
56. France Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
57. France Global Drug Discoveryby Technology 2015-2024 ($ Million)
58. France Global Drug Discoveryby Service 2015-2024 ($ Million)
59. France Global Drug Discoveryby End User 2015-2024 ($ Million)
60. Spain Global Drug Discovery By Drug Type 2015-2024 ($ Million)
61. Spain Global Drug Discovery By Technology 2015-2024 ($ Million)
62. Spain Global Drug Discovery By Service 2015-2024 ($ Million)
63. Spain Global Drug Discoveryby End User 2015-2024 ($ Million)
64. Roe Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
65. Roe Global Drug Discoveryby Technology 2015-2024 ($ Million)
66. Roe Global Drug Discoveryby Service 2015-2024 ($ Million)
67. Roe Global Drug Discoveryby End User Type 2015-2024 ($ Million)
68. India Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
69. India Global Drug Discovery Technology 2015-2024 ($ Million)
70. India Global Drug Discoveryby Service 2015-2024 ($ Million)
71. India Global Drug Discoveryby End User 2015-2024 ($ Million)
72. China Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
73. China Global Drug Discoveryby Technology 2015-2024 ($ Million)
74. China Global Drug Discoveryby Service 2015-2024 ($ Million)
75. China Global Drug Discoveryby End User 2015-2024 ($ Million)
76. Japan Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
77. Japan Global Drug Discoveryby Technology 2015-2024 ($ Million)
78. Japan Global Drug Discoveryby Service 2015-2024 ($ Million)
79. Japan Global Drug Discoveryby End User 2015-2024 ($ Million)
80. Australia Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
81. Australia Global Drug Discoveryby Technology 2015-2024 ($ Million)
82. Australia Global Drug Discoveryby Service 2015-2024 ($ Million)
83. Australia Global Drug Discoveryby End User 2015-2024 ($ Million)
84. Roapac Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
85. Roapac Global Drug Discoveryby Technology 2015-2024 ($ Million)
86. Roapac Global Drug Discoveryby Service 2015-2024 ($ Million)
87. Roapac Global Drug Discoveryby End User 2015-2024 ($ Million)
88. Latin America Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
89. Latin America Global Drug Discoveryby Technology 2015-2024 ($ Million)
90. Latin America Global Drug Discoveryby Service 2015-2024 ($ Million)
91. Latin America Global Drug Discoveryby End User 2015-2024 ($ Million)
92. Mena Global Drug Discoveryby Drug Type 2015-2024 ($ Million)
93. Mena Global Drug Discoveryby Technology 2015-2024 ($ Million)
94. Mena Global Drug Discoveryby Service 2015-2024 ($ Million)
95. Mena Global Drug Discoveryby End User 2015-2024 ($ Million)

List Of Figures
1. Global Drug Discovery Market By Drug Type 2015-2024 ($ Million)
2. Global Small Molecule Drug Market By Geography 2015-2024 ($ Million)
3. Global Biologics Drug Market By Geography 2015-2024 ($ Million)
4. Global Drug Discovery Market By Technology 2015-2024 ($ Million)
5. Global High Throughput Screening Market By Geography 2015-2024 ($ Million)
6. Global Biochips Market By Geography 2015-2024 ($ Million)
7. Global Bioinformatics Market By Geography 2015-2024 ($ Million)
8. Global Pharmacogenomics And Pharmacogenetics Market By Geography 2015-2024 ($ Million)
9. Global Combinatorial Chemistry Market By Geography 2015-2024 ($ Million)
10. Global Nanotechnology Market By Geography 2015-2024 ($ Million)
11. Global Spectroscopy Market By Geography 2015-2024 ($ Million)
12. Global Metabolomics Market By Geography 2015-2024 ($ Million)
13. Global Other Technologies Market By Geography 2015-2024 ($ Million)
14. Global Drug Discovery Market By Service 2015-2024 ($ Million)
15. Global Drug Metabolism And Pharmacokinetics (Dmpk) Services Market By Geography 2015-2024 ($ Million)
16. Global Pharmaceutical Services Market By Geography 2015-2024 ($ Million)
17. Global Chemical Services Market By Geography 2015-2024 ($ Million)
18. Global Biological Services Market By Geography 2015-2024 ($ Million)
19. Global Drug Discovery Market By End User 2015-2024 ($ Million)
20. Global Research Institutes Market By Geography 2015-2024 ($ Million)
21. Global Pharmaceutical Companies Market By Geography 2015-2024 ($ Million)
22. Global Biotechnology Companies Market By Geography 2015-2024 ($ Million)
23. Global Other End Users Market By Geography 2015-2024 ($ Million)
24. United States (U.S.) Drug Discovery Market 2015-2024 ($ Million)
25. Canada Drug Discovery Market 2015-2024 ($ Million)
26. United Kingdom (UK) Drug Discovery Market 2015-2024 ($ Million)
27. France Drug Discovery Market 2015-2024 ($ Million)
28. Germany Drug Discovery Market 2015-2024 ($ Million)
29. Russia Drug Discovery Market 2015-2024 ($ Million)
30. Roe Drug Discovery Market 2015-2024 ($ Million)
31. India Drug Discovery Market 2015-2024 ($ Million)
32. China Drug Discovery Market 2015-2024 ($ Million)
33. Japan Drug Discovery Market 2015-2024 ($ Million)
34. Australia Drug Discovery Market 2015-2024 ($ Million)
35. Roapac Drug Discovery Market 2015-2024 ($ Million)
36. Latin America Drug Discovery Market 2015-2024 ($ Million)
37. Mena Drug Discovery Market 2015-2024 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Astrazeneca (U.K)
  • Covance. (U.S.)
  • Eli Lily (U.S)
  • Glaxosmithkline Plc (UK)
  • Pfizer, Inc. (U.S.)
  • Viva Biotech (China)
  • MORE

Global drug discovery market to worth $70,097 million by 2024

Global drug discovery market was valued at $38,356 million in 2017 and is estimated to generate net revenue of approximately $70,097 million by 2024 growing at a CAGR of 9.0% during forecast period (2017-2024).

Rising prevalence of cancer was estimated at 19 million in 1990 and reached to in 2016, 42 million individuals suffered from different types of cancer (including breast cancer, prostate, colon & rectum, lung cancer and others), as per Our World in Data.

Moreover, as per IDF (U.K.), diabetes prevalence across the globe is expected to reach 629 million by 2045, increasing from 425 million in 2017.

Thus, the prevalence of chronic diseases is expected to drive the global drug discovery market over the forecast period. Further, research and development activities is experiencing high investment from national and international organizations, government of different countries and operating companies.

For instance, as per pharma Association of the British Pharmaceutical Industry (ABPI), global pharmaceutical research and development spending estimated to be $148 billion in 2015 and is further expected to reach to $181 billion by 2022.

Increasing healthcare expenditure to fuel market growth

The rising healthcare expenditure due to rising prevalence diseases is another factor primarily driving the global drug discovery market over the forecasted years. With rising disease prevalence rates and aging population healthcare expenditure across the globe is set to intensify in coming 25 years according to International Health Metrics and Evaluation (IHME).

By 2040, global healthcare expenditure is anticipated to increase from 10.8 trillion in 2018 to $ 20.4 trillion. According to IHME, by 2040 over 9% of global GDP will be spending on healthcare sector.

High income countries are anticipated to spend over $9,019 per person on health by 2040 as compared to upper-middle income ($1,935), lower-middle income ($507) and low-income ($164) countries. Government and public healthcare services would account for over 61% of total healthcare spending across the globe by 2040. Below figure shows, rising trend in healthcare spending by institutions for period 2015-2040.

According to U.S. Centre for Disease Control and Prevention, the annual healthcare expenditure of United States was $3.3 trillion in 2017. However, Canada’s expenditure for healthcare would reach to $253.2 billion in 2018 that accounts for 11.3% of Canada’s gross domestic product (GDP) as per Canadian Institute of Health Information.

Moreover, healthcare expenditure in United Kingdom increased by 3.6% in 2016 as $217.47 billion from $209.9 billion in 2015 as per UK Health Accounts, 2016. Government-financed expenditure on healthcare accounted for 79.4% of total spending in the country.

Technological advancements and innovations: Growth promoter

Technological innovations and various ongoing research activities in drug discovery is promoting the market growth in forecast years. The ongoing clinical trials and research activities for developing drugs and consequently improving their quality with effective translation in clinics are leading the technological advancements in this sector.

In past years, various methodological approaches particularly in drug discovery for improving the delivery of drug candidates and their quality were adopted. Stem cell research is one of the prime examples emerging as new frontier in drug discovery techniques.

In addition, genome editing technologies such as CRISPR/Cas9 for enabling accuracy and precision in alteration of DNA chains is another technological advancement driving the market.

Adoption of AI based technologies and machine learning for mapping cellular pathways, lead optimization chemistry programs and automating histology is enhancing the effectiveness of drug discovery techniques as they have direct impact on target validation and drug discovery.

Latest innovations in drug discovery includes development of biosimulation tools found effective in predicting interaction between proteins and small molecules further revealing the drug binding ability with its target in real-life conditions. Another innovation as per the European Laboratory Research and Innovation Group (2017), is concept of organ-on-a-chip platform that harnesses the advancements in cell biology methods and microfluidic platforms to provide 3-D human tissue systems configured for replicating the physiology of organs.

This would enable researchers to analyze the drug action on organ-like tissues in microfluidic assay systems. Thus, the innovations and technological advancements promoting the drug discovery methods would be driving the market in forecasted years

Geographically, global drug discovery market has been segmented into North America, Europe, Asia Pacific and Rest of World (ROW). North America accounts the largest share in the market owing to high investment in research and development activities from federal government and operating companies. For instance, in 2015, National Science Foundation (NSF) stated that federal agencies have contributed approx. $86 billion to promote basic research on drug development across the country.

In addition, private investments on basic research reached to $24.5 billion in 2015. As per Federal Government, 45% of total population of the country is suffering from at least one chronic disease (including cancer, diabetes and others).Thus, high prevalence of chronic diseases and high investment on research and development activities is expected to drive drug discovery market in the country.

Note: Product cover images may vary from those shown
5 of 4
  • Albany Moleculer Research (U.S.)
  • Astrazeneca (U.K)
  • Bayer (Germany)
  • Boehringer Ingelheim (Germany)
  • Covance. (U.S.)
  • Cyprotex. (U.K.)
  • Eli Lily (U.S)
  • Genscript (U.S)
  • Glaxosmithkline Plc (UK)
  • Johnson And Johnson (U.S)
  • Pfizer, Inc. (U.S.)
  • Quintiles (U.S)
  • Viva Biotech (China)
  • WIL Research Laboratories (U.S.)
  • WuXi Apptech (China)
Note: Product cover images may vary from those shown
Adroll
adroll